The list includes external lower extremity nerve stimulators for restless legs syndrome, computerized behavioral therapy devices for the treatment of fibromyalgia symptoms, SARS-CoV-2 serology tests, infant supine sleep systems, foam or gel chemical sterilant/high-level disinfectants, breast implant suction retrieval systems, and prognostic tests for diagnosing the development or progression of preeclampsia.
One study showed NR at 300 mg/day increased human blood NAD+ ~50% after 8 weeks, whereas higher doses (1000 mg/day) roughly doubled NAD+ levels
Typical Duration of Therapy The duration of BPC-157 therapy varies based on the conditions severity: Acute injuries or mild inflammation: 24 weeks Moderate injuries or post-surgical recovery: 48 weeks Chronic or systemic conditions: 812 weeks or longer For best outcomes, BPC-157 may be combined with TB-500, Thymosin Beta-4, or KPV peptides, along with targeted nutrition and physiologic optimization
Infusion rates may be adjusted to individual tolerance and unique needs